KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lantronix (LTRX) Non-Current Deffered Revenue (2016 - 2025)

Lantronix's Non-Current Deffered Revenue history spans 14 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue fell 19.33% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 19.33%, while the annual FY2025 figure was $2.3 million, 17.58% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $2.0 million at Lantronix, down from $2.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $2.7 million in Q2 2024 and bottomed at $187000.0 in Q1 2021.
  • The 5-year median for Non-Current Deffered Revenue is $1.3 million (2022), against an average of $1.4 million.
  • The largest annual shift saw Non-Current Deffered Revenue skyrocketed 383.17% in 2022 before it fell 25.82% in 2023.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $366000.0 in 2021, then skyrocketed by 232.79% to $1.2 million in 2022, then surged by 97.62% to $2.4 million in 2023, then grew by 4.69% to $2.5 million in 2024, then fell by 19.33% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for LTRX's Non-Current Deffered Revenue are $2.0 million (Q4 2025), $2.1 million (Q3 2025), and $2.3 million (Q2 2025).